FB23-2
- Product Name
- FB23-2
- CAS No.
- 2243736-45-8
- Chemical Name
- FB23-2
- Synonyms
- FB23-2;FB23-2,1.5g;FB23-2 ,S8837;FB23-2, 10 mM in DMSO;FB23-2(FTO Demethylase inhibitor FB23-2);2-[[2,6-Dichloro-4-(3,5-dimethyl-4-isoxazolyl)phenyl]amino]-N-hydroxybenzamide;2-((2,6-Dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)-N-hydroxybenzamide;Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-4-isoxazolyl)phenyl]amino]-N-hydroxy-;FB23 2,AML,Apoptosis,leukemia,acute,anti-proliferation,Inhibitor,FB232,m6A,myeloid,mRNA,inhibit,FB23-2,demethylase,FB-23-2
- CBNumber
- CB84908508
- Molecular Formula
- C18H15Cl2N3O3
- Formula Weight
- 392.24
- MOL File
- 2243736-45-8.mol
FB23-2 Property
- Density
- 1.428±0.06 g/cm3(Predicted)
- storage temp.
- under inert gas (nitrogen or Argon) at 2-8°C
- solubility
- DMSO:70.25(Max Conc. mg/mL);179.1(Max Conc. mM)
- form
- A solid
- pka
- 8.72±0.40(Predicted)
- color
- White to light yellow
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P233Keep container tightly closed.
P260Do not breathe dust/fume/gas/mist/vapours/spray.
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P271Use only outdoors or in a well-ventilated area.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352IF ON SKIN: wash with plenty of soap and water.
P304IF INHALED:
P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P312Call a POISON CENTER or doctor/physician if you feel unwell.
P321Specific treatment (see … on this label).
P332+P313IF SKIN irritation occurs: Get medical advice/attention.
P337+P313IF eye irritation persists: Get medical advice/attention.
P340Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P362Take off contaminated clothing and wash before reuse.
P403Store in a well-ventilated place.
P403+P233Store in a well-ventilated place. Keep container tightly closed.
P405Store locked up.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- orb611563
- Product name
- FB23-2 (FTO Demethylase inhibitor FB23-2)
- Packaging
- 100mg
- Price
- $1654.1
- Updated
- 2021/12/16
- Product number
- orb611563
- Product name
- FB23-2 (FTO Demethylase inhibitor FB23-2)
- Packaging
- 250mg
- Price
- $3282.7
- Updated
- 2021/12/16
- Product number
- orb611563
- Product name
- FB23-2 (FTO Demethylase inhibitor FB23-2)
- Packaging
- 1g
- Price
- $6545
- Updated
- 2021/12/16
- Product number
- DC23119
- Product name
- FB23-2(FTODemethylaseinhibitorFB23-2)
- Purity
- >98%
- Packaging
- 100mg
- Price
- $800
- Updated
- 2021/12/16
- Product number
- DC23119
- Product name
- FB23-2(FTODemethylaseinhibitorFB23-2)
- Purity
- >98%
- Packaging
- 1g
- Price
- $2800
- Updated
- 2021/12/16
FB23-2 Chemical Properties,Usage,Production
Uses
FB23-2 is a potent and selective inhibitor of mRNA N6-methyladenosine (m6A) demethylase FTO, with an IC50 of 2.6 μM. FB23-2 has anti-proliferation activity. FB23-2 can be used for the research of acute myeloid leukemia (AML)[1].
in vivo
FB23-2 (2 mg/kg; i.p.; daily; for 10 days) substantially suppresses leukemia progression and prolongs survival[1].
FB23-2 exhibits elimination half-life (rat 6.7 h) and Cmax (rat 2421.3 ng/mL) following intraperitoneal injection (rat 3 mg/kg)[1].
| Animal Model: | NOD/LtSz-scid IL2RG-SGM3 (NSGS) mice, xeno-transplanted with MONOMAC6 AML cells[1] |
| Dosage: | 2 mg/kg |
| Administration: | Intraperitoneal injection, daily, for 10 days |
| Result: | Delayed the onset of full-blown leukemic symptoms and significantly prolonged survival by almost doubling the median survival. |
| Animal Model: | Sprague Dawley (SD) rats[1] |
| Dosage: | 3 mg/kg (Pharmacokinetic Analysis) |
| Administration: | Intraperitoneal injection |
| Result: | T1/2 (6.7 hours), Cmax (2421.3 ng/mL). |
References
[1] Huang Y, et al. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia. Cancer Cell. 2019 Apr 15;35(4):677-691.e10. DOI:10.1016/j.ccell.2019.03.006
FB23-2 Preparation Products And Raw materials
Raw materials
Preparation Products
FB23-2 Suppliers
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- +1-708-310-1919 +1-13798911105
- Fax
- 708-557-7486
- sales@invivochem.cn
- Country
- United States
- ProdList
- 6391
- Advantage
- 58
- Tel
- tp@aladdinsci.com
- Country
- United States
- ProdList
- 57505
- Advantage
- 58
- Tel
- +1-781-999-5354;
- support@targetmol.com
- Country
- United States
- ProdList
- 39035
- Advantage
- 58
- Tel
- --
- Fax
- --
- cayman@caymanchem.com
- Country
- United States
- ProdList
- 6213
- Advantage
- 81